Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Arja Helin‐Salmivaara

Biographic Data

ID10401468
NAMEArja Helin‐Salmivaara
GIVEN NAMESArja
FAMILY NAMEHelin‐Salmivaara
SIGNATURESALMIVAARA A H
AFFILIATIONSUniversity of Turku
VERIFIEDNo
TOTAL WORKS2
TOTAL CITATIONS0
AUTHOR COUNT2
EDITOR COUNT0
FIRST PUBLICATION YEAR2010
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Residents’ and preceptors’ perceptions on newly introduced milestones—a qualitative study in general practice/family medicine in Finland

    Open Access•Veera Veromaa, Virpi Kultanen et al.•ARTICLE•BMC Medical Education•2026

    BACKGROUND: In the context of competency-based postgraduate education, professional progression is often tracked through milestones, particularly in North American settings. This study aimed to explore the perceptions of residents and preceptors regarding newly implemented milestones in self-assessment and formative assessment within Finland's 6-year national postgraduate education (PGE) program for family medicine/general practice. METHOD: We co…

  • Impact of Restricted Reimbursement on the Use of Statins in Finland: A Register-Based Study

    Jaana E Martikainen, Leena K Saastamoinen et al.•ARTICLE•Medical Care•2010•References: 12

    OBJECTIVES: New and expensive medicines are a driving force behind growth in medicine costs, and policies promoting use of less expensive products have been widely introduced. This study investigated the short-term consequences of the restricted reimbursement of expensive statins (atorvastatin and rosuvastatin) on the use of statins in Finland. METHODS: Data on patients purchasing atorvastatin, rosuvastatin, or simvastatin in 2002-2007 were retri…

No prominent works on this page.

  • Impact of Restricted Reimbursement on the Use of Statins in Finland: A Register-Based Study

    Jaana E Martikainen, Leena K Saastamoinen et al.•ARTICLE•Medical Care•2010•References: 12

    OBJECTIVES: New and expensive medicines are a driving force behind growth in medicine costs, and policies promoting use of less expensive products have been widely introduced. This study investigated the short-term consequences of the restricted reimbursement of expensive statins (atorvastatin and rosuvastatin) on the use of statins in Finland. METHODS: Data on patients purchasing atorvastatin, rosuvastatin, or simvastatin in 2002-2007 were retri…

  • Residents’ and preceptors’ perceptions on newly introduced milestones—a qualitative study in general practice/family medicine in Finland

    Open Access•Veera Veromaa, Virpi Kultanen et al.•ARTICLE•BMC Medical Education•2026

    BACKGROUND: In the context of competency-based postgraduate education, professional progression is often tracked through milestones, particularly in North American settings. This study aimed to explore the perceptions of residents and preceptors regarding newly implemented milestones in self-assessment and formative assessment within Finland's 6-year national postgraduate education (PGE) program for family medicine/general practice. METHOD: We co…

Atorvastatin (1 works) · Cholesterol (1 works) · Clinical Reasoning and Diagnostic Skills (1 works) · Diabetes mellitus (1 works) · Economics (1 works) · Health care (1 works) · Health Systems, Economic Evaluations, Quality of Life (1 works) · Hyperlipidemia (1 works) · Innovations in Medical Education (1 works) · Internal Medicine (1 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae